(Q28254231)

English

Pharmacoeconomic analysis of cefmenoxime dual individualization in the treatment of nosocomial pneumonia

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Pharmacoeconomic analysis of cefmenoxime dual individualization in the treatment of nosocomial pneumonia (English)

0 references

1 reference

1 reference

ChEBI release 2020-05-28

J A Paladino

1

0 references

R E Fell

series ordinal

2

0 references

language of work or name

English

0 references

publication date

March 1994

0 references

published in

Annals of Pharmacotherapy

0 references

volume

28

0 references

issue

3

0 references

page(s)

384-9

0 references

cites work

Regulation of the pharmaceutical industry and now pharmacoeconomic research?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F106002809402800316

retrieved

21 January 2018

Economic Aspects of Pharmacokinetic Services

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F106002809402800316

retrieved

21 January 2018

Cefmenoxime in the treatment of nosocomial pneumonias in critical care patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F106002809402800316

retrieved

21 January 2018

APACHE II: a severity of disease classification system

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F106002809402800316

retrieved

21 January 2018

Clinical economics. A guide to the economic analysis of clinical practices

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F106002809402800316

retrieved

21 January 2018

Evaluating the cost-effectiveness of treatment with third-generation cephalosporins

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F106002809402800316

retrieved

21 January 2018

Third generation cephalosporins: safety profiles after 10 years of clinical use.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F106002809402800316

retrieved

21 January 2018

Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F106002809402800316

retrieved

21 January 2018

Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F106002809402800316

retrieved

21 January 2018

Identifiers

DOI

10.1177/106002809402800316

0 references

PubMed publication ID

8193431

0 references

(Q28254231)

Pharmacoeconomic analysis of cefmenoxime dual individualization in the treatment of nosocomial pneumonia

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)